Catalent agrees to buy Juniper for $133m

04-07-2018

Catalent agrees to buy Juniper for $133m

Xesai / iStockphoto.com

US-based Catalent, which provides delivery technologies for drugs, has agreed to buy Juniper Pharmaceuticals for $133 million.


Catalent, Juniper Pharmaceuticals, mergers and acquisitions, Crinone, drug development

LSIPR